IriSys Competitors

Kemwell is a contract biologics development and CMO company providing services to global biopharmaceutical organizations. Kemwell facilities, located in Bangalore, India, are designed and developed with technological support from a leading German pharma company. Kemwell provides customers with cost-effective access to state-of-the-art technology for all mammalian cell culture based products’ development and manufacturing. 15,000 sq. m. Kemwell facility consists of a cGMP drug substance manufacturing area with over 4500L bioreactor capacity, sterile fill and finish areas for cGMP drug product manufacturing and process development laboratories to support production of protein therapeutics from mammalian-cell culture – monoclonal antibodies, bi-specific antibodies, fusion proteins, etc. Kemwell is capable of supporting novel, bio-better and biosimilar programs’ preclinical development, clinical development, cGMP clinical manufacturing and cGMP commercial manufacturing. Kemwell, having established in 1980, had long term associations with pharma majors such as Bayer, GlaxoSmithKline, Merck KGaA, Novartis, Pfizer and others for small molecule contract mfg. and R&D. In 2016, Kemwell divested its small-molecule division to focus on biologics, leveraging its vast and rich experience. Kemwell is now a 100% biologics CDMO.

Emerson Resources is a pharmaceutical services provider located in Norristown, PA. Offering preformulation through phase II clinical supplies manufacturing services, our highly trained staff and state of the art manufacturing facility are available to support all of your drug product development needs. Emerson also maintains a Schedule I - V analytical license and Schedule II - V manufacturing license for DEA controlled substances. Our formulation development expertise is focused on solid and non-sterile liquid products including tablets, capsules, creams, ointments, oral solutions and suspensions. In addition, Emerson manufactures several value added ingredients including Marcoat 125 and PlasACRYL T20. These coating system additives improve physical properties, speed process time, and reduce costs.

LATITUDE Pharmaceuticals is a leading-edge CDMO providing innovative drug formulation and GMP manufacturing services to the biotech and pharmaceutical industries, offering expertise in formulating insoluble, unstable, and other problematic drug molecules. We focus our expertise, acquired from years of experience, to develop leading-edge formulations and intellectual property for our clients. In addition to these services, our internal reformulation programs are actively creating out license-ready, proprietary drug delivery technologies as well as 505(b)(2) NDA opportunities through innovative formulations.